您的位置:阿仪网 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > 江苏酶联生物科技有限公司 > 产品展示 > 抗体 > 一抗 > FITC标记的低密度脂蛋白受体衔接蛋白抗体

联系我们

联系人:邵大卫

点击查看联系方式

elisa试剂盒

标准品

生化试剂

培养基

血清

细胞

抗体

产品展示

FITC标记的低密度脂蛋白受体衔接蛋白抗体

FITC标记的低密度脂蛋白受体衔接蛋白抗体

点击次数:93

价格:¥电议

更新日期:2026/8/7 18:14:45

生 产 地:中国大陆

产品型号:

简单介绍:FITC标记的低密度脂蛋白受体衔接蛋白抗体产品介绍:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications

商家名片
邵**
联系我时,请说明是阿仪网看到的,谢谢!
  • 电话: 15******997
  • 手机: 15******997
  • 微信:
  • 交换名片后展示联系方式 → →
相关标签:FITC标记的低密度脂蛋白受体衔接蛋白抗体

详细内容

英文名称 Anti-ARH/FITC
中文名称 FITC标记的低密度脂蛋白受体衔接蛋白抗体
别 名 ARH; ARH GENE; ARH_HUMAN; ARH1; ARH2; Autosomal recessive hypercholesterolemia protein; FHCB1; FHCB2; LDL receptor adaptor protein; Ldlrap1; Low density lipoprotein receptor adapter protein 1.
说 明 书 100ul
研究领域 心血管 细胞生物
抗体来源 Rabbit
克隆类型 Polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep,
产品应用 IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 34kDa
性 状 Lyophilized or Liquid
浓 度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human ARH/LDL receptor adaptor protein
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
产品介绍 background:
The protein encoded by this gene is a cytosolic protein which contains a phosphotyrosine binding (PTD) domain. The PTD domain has been found to interact with the cytoplasmic tail of the LDL receptor. Mutations in this gene lead to LDL receptor malfunction and cause the disorder autosomal recessive hypercholesterolaemia.

Function:
Adapter protein (clathrin-associated sorting protein (CLASP)) required for efficient endocytosis of the LDL receptor (LDLR) in polarized cells such as hepatocytes and lymphocytes, but not in non-polarized cells (fibroblasts). May be required for LDL binding and internalization but not for receptor clustering in coated pits. May facilitate the endocytocis of LDLR and LDLR-LDL complexes from coated pits by stabilizing the interaction between the receptor and the structural components of the pits. May also be involved in the internalization of other LDLR family members. Binds to phosphoinositides, which regulate clathrin bud assembly at the cell surface.

Subunit:
Interacts with LDLR. Binds to soluble clathrin trimers. Interacts with AP2B1; the interaction mediates the association with the AP-2 complex. Interacts with VLDLR

Subcellular Location:
Cytoplasm.

Tissue Specificity:
Expressed at high levels in the kidney, liver, and placenta, with lower levels detectable in brain, heart, muscle, colon, spleen, intestine, lung, and leukocytes.

Post-translational modifications:
Phosphorylated upon DNA damage, probably by ATM or ATR.

DISEASE:
Defects in LDLRAP1 are the cause of autosomal recessive hypercholesterolemia (ARH) [MIM:603813]. ARH is a disorder caused by defective internalization of LDL receptors (LDLR) in the liver. ARH has the clinical features of familial hypercholesterolemia (FH) [MIM:143890] homozygotes, including severely elevated plasma LDL cholesterol, tuberous and tendon xanthomata, and premature atherosclerosis. LDL receptor (LDLR) activity measured in skin fibroblasts is normal, as the LDL binding ability.
FITC标记的低密度脂蛋白受体衔接蛋白抗体

采购记录

优质供应

相关文章

  • 友情链接
  • 热词推荐
在线咨询5分钟应答

提交